Anjee Davis



Anjelica (“Anjee”) Davis serves as President of Fight Colorectal Cancer (Fight CRC), a national patient-empowerment organization founded in 2005. For over 15 years, she has focused her work on colorectal cancer research, education, and awareness. Prior to joining Fight Colorectal Cancer, she worked at the University of South Carolina’s Center for Colon Cancer Research, administering over $11 million dollars from the National Institute of Health (NIH) to build a multidisciplinary basic science team of young investigators in colorectal cancer. Her experience spans from leading public health efforts and developing statewide colorectal cancer screening programs to managing a community oncology practice and overseeing its clinical trials program. Anjee brings a unique understanding of cancer research as well as clinical systems to her position at Fight CRC.

Anjee was a founding member of the National Colorectal Cancer Roundtable’s (NCCRT) committee that leads the 80% in Every Community effort to increase colorectal cancer screening nationwide. She serves as the co-chair of the Awareness Task Force for the NCCRT and serves as a steering committee member (2009-2012; 2017-present). She also actively serves on Patient-Centered Outcomes Research Institute (PCORI) advisory panels and is a member of the Cancer Leadership Council, Research!America, One Voice Against Cancer (OVAC), and Alliance for a Stronger FDA. As a research advocate, Anjee serves on several committees to include: NCI’s Colon Cancer Task Force, Patient Advocate Steering Committee, Stand Up to Cancer (SU2C) Dream Team Patient Advocate and was selected to be a DIA Fellow.

In 2019, Dr. Ned Sharpless confirmed her appointment to the National Cancer Institute’s (NCI) Council of Research Advocates (NCRA), and Dr. James Doroshow, Deputy Director for Clinical and Translational Research at the NCI, appointed her to be a member of NCI’s Clinical Trials and Translational Research Advisory Committee (CTAC). This federal advisory committee makes recommendations to the NCI on the conduct of clinical trials and translational research across the Institute. In 2020, she was appointed to NCI’s Gastrointestinal Cancer Steering Committee (GISC). A voice for patients, she reviews design, prioritizations, and evaluates concepts for phase 2 and phase 3 clinical trials in adult gastrointestinal cancers.

Recognizing her commitment to community service and advocacy, Anjee has received the Betty Anne Moore Community Leadership Award, the Prevent Cancer Foundation’s Laurel Award for Advocacy, and was honored by the Springfield, Missouri Business Journal’s 40 under 40 for her civic leadership. Building collaborations is an important part of her role, and she is best known for championing patient empowerment within the research and healthcare community. Anjee holds a bachelor’s degree from Southwest Missouri State University and a Master of Public Policy Administration from the University of Missouri-St. Louis.